Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
Kallistatin, an endogenous serine proteinase inhibitor, is protective against sepsis in animal models. The aim of this study was to determine the plasma concentration of kallistatin in intensive care unit (ICU) patients with severe sepsis and septic shock and to determine their potential correlation...
Main Authors: | Wei-Chieh Lin, Chang-Wen Chen, Lee Chao, Julie Chao, Yee-Shin Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5443576?pdf=render |
Similar Items
-
Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock.
by: Simon Kreü, et al.
Published: (2017-01-01) -
Correction: Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock.
by: PLOS ONE Staff
Published: (2017-01-01) -
Dynamics of brain natriuretic peptide in critically ill patients with severe sepsis and septic shock
by: Amr S Omar, et al.
Published: (2013-01-01) -
Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children
by: Fatih Aygün, et al.
Published: (2019-07-01) -
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
by: Oscar H. M. Lundberg, et al.
Published: (2020-11-01)